Legislative mandate exists to address unfair prices in pharma sector, says EU enforcer
Despite the difficulty of pursuing excessive-pricing cases in the pharmaceuticals sector, the European Commission has a legislative mandate to go after such concerns, a director at the EU enforcer has said.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.